PlainPharmaWatch

CMS Open Payments · Program Year 2024

Hospira, Inc.

Hospira, Inc. reported $21,600.38 across General Payments, Research, and Ownership to 1,203 physicians and teaching hospitals across 1,203 transactions.

See the rankings → How this is sourced
$21.6K
All-tracks total
1,203
Transactions
1,203
Recipients
+$12.6K
General Payments vs PY2023

Hospira, Inc. reported $21,600.38 across all CMS Open Payments tracks (General + Research + Ownership) to 1,203 physicians and teaching hospitals in Program Year 2024 - ranking #1526 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $21,600.38, averaging $17.96 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer hospira-inc Hospira, Inc.

$21.6K · #1526/1,925 · 0.0% industry · PY2024

  • TOT $21.6K
  • RANK #1526
  • SHARE 0.0%
  • TXN 1,203
  • RCP 1,203
  • CAT 1
  • GEN $21.6K
  • ΔGEN +$12.6K
  • TOP1 1.1%
  • PY 2024

Volume peers

Nearest volume peer: Nobelpharma America, LLC ($21.7K)

Oxford Performance Materials…$21.8KNobelpharma America, LLC$21.7KHospira, Inc. (this)$21.6KABC Home Medical Supply, Inc.$21.4KTeikoku Pharma USA, Inc.$21.4K
All-tracks payment totals near Hospira, Inc. (CMS Open Payments PY2024)

Hospira, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Hospira, Inc.'s CMS-reported General Payments increased by $12.6K (+140.2%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: HOSPIRA, INC.PY2023: HOSPIRA, INC.PY2024: HOSPIRA, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$9.0KPY2024$21.6K
PY2023
$8,992.02
PY2024
$21,600.38

What the Data Shows for Hospira, Inc.

Hospira, Inc. ranks #1526 out of 1,925 companies in the CMS Open Payments database for Program Year 2024, a comparatively small 0.0% slice of all industry payments reported nationwide for the year. The underlying total is $21,600.38 across 1,203 transactions to 1,203 physicians and teaching hospitals - $17.96 per transaction and $17.96 per recipient on average.

1,203 transactions worth $21.6K make "Food and Beverage" the top general-payment category in the 1-category breakdown below, 100.0% of General Payments (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Hospira, Inc. made 1 types of general payments. "Food and Beverage" is the largest category at $21.6K, 100.0% of General Payments.

How Hospira, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Food and Beverage$21.6K
Payment Type Amount Transactions
Food and Beverage $21.6K 1,203

Recipient Concentration in General Payments

The five largest recipient relationships account for $1,079.24 (5.0%) of $21,600.38 in this company's General Payments records across 588 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Hospira, Inc.

The five named recipients with the highest reported General Payments from this company

Sara Powell$233.00Cori Passer$229.42Celina Bernabe$212.90Nancy Olson$202.76Aruna Baratham$201.16
  1. 1

    Sara Powell

    $233.00 across 17 reported transactions

  2. 2

    Cori Passer

    $229.42 across 16 reported transactions

  3. 3

    Celina Bernabe

    $212.90 across 14 reported transactions

  4. 4

    Nancy Olson

    $202.76 across 13 reported transactions

  5. 5

    Aruna Baratham

    $201.16 across 13 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Hospira, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Hospira, Inc..

Hydrofera LLC

HHI 31

Inogen, Inc.

HHI 32

Galderma Laboratories, L.P.

HHI 29

Salix Pharmaceuticals, a division of Bausch Health US, LLC

HHI 33

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Hospira, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Hospira, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.